Net sales in the quarter were $371 million compared with $357 million in last year’s December quarter (+4% core sales (1)). Net income from continuing operations was $36 million (diluted EPS from ...

Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader in the design, engineering, and manufacturing of critical fluid delivery ...

Q1 2025 Earnings Call Transcript February 3, 2025 Operator: Good day. Thank you for standing by. Welcome to Twist ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

The town’s financial standing is trending in the right direction according to an end-of-fiscal-year 2024 audit which showed ...